• Board of Directors
  • Documents & Charters
  • Committee Composition
  • Expanded Access

    • Topic Category: Prostate Cancer

    Our Company
    Our Focus
    Our Science
    Our Medicines
    Our Advocacy
    Join the Team
    For Media
    Contact Us

    © 2023 Myovant Sciences GmbH. All rights reserved.

    OUR COMPANY
    Our Purpose
    Our Leadership
    Our Locations
    OUR FOCUS
    The Problem
    Uterine Fibroids
    Endometriosis
    Prostate Cancer
    Infertility
    OUR SCIENCE
    Pipeline
    Relugolix Combination Tablet
    MVT-602
    OUR MEDICINES
    OUR ADVOCACY
    Forward Together
    JOIN THE TEAM
    Our Culture
    Our Benefits
    Open Positions
    INVESTORS & MEDIA
    Company Overview
    News & Events
    Stock Information
    Financials & Filings
    Corporate Governance
    Email Alerts
    CONTACT US
    TWITTER
    LINKEDIN
    Instagram